[1]Komoto,Teruo;Hirota,Hiroyuki;Otsuka,Mari;Kotake,Jiro;Hasegawa,Susumu;Koya,Hidehiko;Sato,Susumu;Sakamoto,Takao[ChemicalandPharmaceuticalBulletin,2000,vol.48,#12,p.1978-1985]
1370256-42-0
10272-49-8
119193-19-0
142047-94-7
160132-91-2
161609-76-3
1084-45-3 | Ethyl 7-hydroxycoumarin-4-carboxylate | AA007CLI | MFCD00174422
17216-10-3 | 1,3-Bis(1-naphthalenyloxy)-2-propanol | AA007D4O | MFCD27966921
151878-23-8 | 1,4,7,10-Tetraazacyclododecane-1,4,7-triaceticacid, 10-[(1R,2S)-2,3-dihydroxy-1-(hydroxymethyl)propyl]-, calcium salt (1:1),rel- | AA007DT0
109925-10-2 | 1,3-Dimethyl-5-phenoxy-1H-pyrazole-4-carbaldehyde | AA007ECD | MFCD07698583
345637-71-0 | (5-Methyl-3-trifluoromethyl-pyrazol-1-yl)-acetic acid | AA007ETB | MFCD00297315
33422-35-4 | Ethyl 2-(3-oxo-2-piperazinyl)acetate | AA007FB9 | MFCD00052897
333985-79-8 | 1-(Dimethylcarbamoyl)piperidine-4-carboxylic acid | AA007FRV | MFCD03830325
154235-83-3 | Piperidin-1-yl(quinoxalin-6-yl)methanone | AA007G8K | MFCD00943201
3230-94-2 | L-Ornithine l-aspartate salt | AA007GQE | MFCD00058084
34825-70-2 | 1-Amino-5-hexene | AA007H68 | MFCD02258452
